Research on accurate screening and diagnosis system of coronary artery disease based on serum multi-omics study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035437

Enrollment

Unknown

Registered

2020-08-11

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Gold Standard:Clinical outcome

Index test:coronary&#32

the&#32

(APOE,&#32

APO,&#32

Apo4&#32

precursor,&#32

complement&#32

C3,&#32

kininase-1,&#32

C1q&#32

subunit&#32

C,&#32

Eligibility

Sex/Gender

All

Age

15 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Volunteered to participate in this trial and signed informed consent; (2) Aged more than 18 Years; (3) Suspected as Coronary heart disease and Planned to execute Coronary angiography.

Exclusion criteria

Exclusion criteria: 1. Patients with renal failure requiring long-term hemodialysis; 2. Traumatic patients; 3. Patients who have recently undergone cardioversion, defibrillation or thrombolytic therapy; 4. Patients who underwent coronary artery bypass graft surgery within the last month or who were hospitalized for acute myocardial infarction within the last 3 weeks; 5. Pregnant and lactating women; 6. Mentally retarded patients; 7. Patients with abnormal mental state.

Design outcomes

Primary

Measure	Time frame
Serum proteome;Serum lipidome;Serum metabolome;SEN, SPE, ACC, AUC of ROC;	—

Contacts

Public ContactBaishen Pan

Zhongshan Hospital affiliated to Fudan University

pan.baishen@zs-hospital.sh.cn+86 18817976583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026